The Supreme Court has observed that considerable unexplained delay on the part of Drug authorities to test a sample can render any penalty under Drugs and Cosmetics Act, 1940, based upon the said analysis of the sample, as void. The bench comprising Justices RF Nariman and Navin Sinha was considering an appeal filed by Medipol Pharmaceutical India Pvt. Ltd. which was blacklisted. The...